Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1996 Jun 15;97(12):2736–2744. doi: 10.1172/JCI118728

Role of lysophosphatidylcholine in the inhibition of endothelial cell motility by oxidized low density lipoprotein.

G Murugesan 1, P L Fox 1
PMCID: PMC507366  PMID: 8675684

Abstract

Endothelial cell (EC) movement is required for the development and repair of blood vessels. We have previously shown that LDL oxidized by transition metals almost completely suppressed the wound-healing migratory response of vascular EC in vitro. We now report that lysophosphatidylcholine (lysoPC), a lipid component of oxidized LDL, has an important role in the antimigratory activity of the lipoprotein. Purified 1-palmitoyl lysoPC inhibited movement with a half-maximal activity at 12-15 micrometers, and near complete inhibition at 20 micrometers; the inhibitory concentration of lysoPC was consistent with its abundance in oxidized LDL. The inhibition was not due to cytotoxicity since protein synthesis was unaffected and since EC movement was restored after removal of lysoPC. Lysophospholipid activity was dependent on lipid structure. LysoPC's containing 1-position C16 or C18 saturated fatty acids were antimigratory, but those containing C < or = 14 saturated fatty acids or polyunsaturated fatty acids were not. The activity of 1-palmitoyl lysolipids with various head groups was examined. Lysophosphatidylinositol was more antimigratory than lysophosphatidylglycerol and lysophosphatidylcholine, which were more potent than lysophosphatidylserine and lysophosphatidylethanolamine. Monoglyceride was inactive while lysophosphatidate had promigratory activity. These results are consistent with head group size rather than charge as a critical determinant of activity. To show that lysophospholipids within an intact lipoprotein were active, LDL was treated with bee venom phospholipase A2 (PLA2). The modified lipoprotein inhibited EC movement to the same extent as iron-oxidized LDL and antimigratory activity correlated with the amount of lysoPC formed. To determine antimigratory activity of lysoPC present in oxidized LDL, lipid extracts from oxidized LDL were fractionated by normal phase HPLC. The fraction comigrating with lysoPC had nearly the same activity as the total extract confirming that lysoPC (or a co-eluting lipid) was a major antimigratory molecule in oxidized LDL. These studies demonstrate that lysoPC in oxidized LDL limit EC wound healing responses in vitro, and suggest a possible role for lysolipids in limiting endothelial regeneration after a denuding injury in vivo.

Full Text

The Full Text of this article is available as a PDF (398.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Addis P. B., Emanuel H. A., Bergmann S. D., Zavoral J. H. Capillary GC quantification of cholesterol oxidation products in plasma lipoproteins of fasted humans. Free Radic Biol Med. 1989;7(2):179–182. doi: 10.1016/0891-5849(89)90011-7. [DOI] [PubMed] [Google Scholar]
  2. Ausprunk D. H., Folkman J. Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis. Microvasc Res. 1977 Jul;14(1):53–65. doi: 10.1016/0026-2862(77)90141-8. [DOI] [PubMed] [Google Scholar]
  3. Autio I., Jaakkola O., Solakivi T., Nikkari T. Oxidized low-density lipoprotein is chemotactic for arterial smooth muscle cells in culture. FEBS Lett. 1990 Dec 17;277(1-2):247–249. doi: 10.1016/0014-5793(90)80857-f. [DOI] [PubMed] [Google Scholar]
  4. Berliner J. A., Territo M. C., Sevanian A., Ramin S., Kim J. A., Bamshad B., Esterson M., Fogelman A. M. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J Clin Invest. 1990 Apr;85(4):1260–1266. doi: 10.1172/JCI114562. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bjornsson T. D., Dryjski M., Tluczek J., Mennie R., Ronan J., Mellin T. N., Thomas K. A. Acidic fibroblast growth factor promotes vascular repair. Proc Natl Acad Sci U S A. 1991 Oct 1;88(19):8651–8655. doi: 10.1073/pnas.88.19.8651. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Boissonneault G. A., Wang Y., Chung B. H. Oxidized low-density lipoproteins delay endothelial wound healing: lack of effect of vitamin E. Ann Nutr Metab. 1995;39(1):1–8. doi: 10.1159/000177836. [DOI] [PubMed] [Google Scholar]
  7. Chatterjee S. Role of oxidized human plasma low density lipoproteins in atherosclerosis: effects on smooth muscle cell proliferation. Mol Cell Biochem. 1992 Apr;111(1-2):143–147. doi: 10.1007/BF00229586. [DOI] [PubMed] [Google Scholar]
  8. Chisolm G. M., Ma G., Irwin K. C., Martin L. L., Gunderson K. G., Linberg L. F., Morel D. W., DiCorleto P. E. 7 beta-hydroperoxycholest-5-en-3 beta-ol, a component of human atherosclerotic lesions, is the primary cytotoxin of oxidized human low density lipoprotein. Proc Natl Acad Sci U S A. 1994 Nov 22;91(24):11452–11456. doi: 10.1073/pnas.91.24.11452. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Connolly D. T., Heuvelman D. M., Nelson R., Olander J. V., Eppley B. L., Delfino J. J., Siegel N. R., Leimgruber R. M., Feder J. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest. 1989 Nov;84(5):1470–1478. doi: 10.1172/JCI114322. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Coomber B. L., Gotlieb A. I. In vitro endothelial wound repair. Interaction of cell migration and proliferation. Arteriosclerosis. 1990 Mar-Apr;10(2):215–222. doi: 10.1161/01.atv.10.2.215. [DOI] [PubMed] [Google Scholar]
  11. DiCorleto P. E., de la Motte C. A. Characterization of the adhesion of the human monocytic cell line U937 to cultured endothelial cells. J Clin Invest. 1985 Apr;75(4):1153–1161. doi: 10.1172/JCI111810. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Flavahan N. A. Lysophosphatidylcholine modifies G protein-dependent signaling in porcine endothelial cells. Am J Physiol. 1993 Mar;264(3 Pt 2):H722–H727. doi: 10.1152/ajpheart.1993.264.3.H722. [DOI] [PubMed] [Google Scholar]
  13. Fong L. G., Fong T. A., Cooper A. D. Inhibition of lipopolysaccharide-induced interleukin-1 beta mRNA expression in mouse macrophages by oxidized low density lipoprotein. J Lipid Res. 1991 Dec;32(12):1899–1910. [PubMed] [Google Scholar]
  14. Fox P. L., DiCorleto P. E. Modified low density lipoproteins suppress production of a platelet-derived growth factor-like protein by cultured endothelial cells. Proc Natl Acad Sci U S A. 1986 Jul;83(13):4774–4778. doi: 10.1073/pnas.83.13.4774. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Gaziano J. M., Manson J. E., Buring J. E., Hennekens C. H. Dietary antioxidants and cardiovascular disease. Ann N Y Acad Sci. 1992 Sep 30;669:249–259. doi: 10.1111/j.1749-6632.1992.tb17104.x. [DOI] [PubMed] [Google Scholar]
  16. Gotlieb A. I., Spector W., Desai K., Steiner G. The effect of low density lipoprotein on in vitro porcine endothelial cell reendothelialization. Artery. 1983;12(2):132–144. [PubMed] [Google Scholar]
  17. Hamilton T. A., Ma G. P., Chisolm G. M. Oxidized low density lipoprotein suppresses the expression of tumor necrosis factor-alpha mRNA in stimulated murine peritoneal macrophages. J Immunol. 1990 Mar 15;144(6):2343–2350. [PubMed] [Google Scholar]
  18. Henriksen T., Mahoney E. M., Steinberg D. Enhanced macrophage degradation of biologically modified low density lipoprotein. Arteriosclerosis. 1983 Mar-Apr;3(2):149–159. doi: 10.1161/01.atv.3.2.149. [DOI] [PubMed] [Google Scholar]
  19. Hessler J. R., Morel D. W., Lewis L. J., Chisolm G. M. Lipoprotein oxidation and lipoprotein-induced cytotoxicity. Arteriosclerosis. 1983 May-Jun;3(3):215–222. doi: 10.1161/01.atv.3.3.215. [DOI] [PubMed] [Google Scholar]
  20. Hoffman R. D., Kligerman M., Sundt T. M., Anderson N. D., Shin H. S. Stereospecific chemoattraction of lymphoblastic cells by gradients of lysophosphatidylcholine. Proc Natl Acad Sci U S A. 1982 May;79(10):3285–3289. doi: 10.1073/pnas.79.10.3285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Jalink K., Moolenaar W. H., Van Duijn B. Lysophosphatidic acid is a chemoattractant for Dictyostelium discoideum amoebae. Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):1857–1861. doi: 10.1073/pnas.90.5.1857. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Jougasaki M., Kugiyama K., Saito Y., Nakao K., Imura H., Yasue H. Suppression of endothelin-1 secretion by lysophosphatidylcholine in oxidized low density lipoprotein in cultured vascular endothelial cells. Circ Res. 1992 Sep;71(3):614–619. doi: 10.1161/01.res.71.3.614. [DOI] [PubMed] [Google Scholar]
  23. Kalant N., McCormick S., Parniak M. A. Effects of copper and histidine on oxidative modification of low density lipoprotein and its subsequent binding to collagen. Arterioscler Thromb. 1991 Sep-Oct;11(5):1322–1329. doi: 10.1161/01.atv.11.5.1322. [DOI] [PubMed] [Google Scholar]
  24. Keegan A., Hill C., Kumar S., Phillips P., Schor A., Weiss J. Purified tumour angiogenesis factor enhances proliferation of capillary, but not aortic, endothelial cells in vitro. J Cell Sci. 1982 Jun;55:261–276. doi: 10.1242/jcs.55.1.261. [DOI] [PubMed] [Google Scholar]
  25. Kita T., Nagano Y., Yokode M., Ishii K., Kume N., Ooshima A., Yoshida H., Kawai C. Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. Proc Natl Acad Sci U S A. 1987 Aug;84(16):5928–5931. doi: 10.1073/pnas.84.16.5928. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Koch A. E., Polverini P. J., Kunkel S. L., Harlow L. A., DiPietro L. A., Elner V. M., Elner S. G., Strieter R. M. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science. 1992 Dec 11;258(5089):1798–1801. doi: 10.1126/science.1281554. [DOI] [PubMed] [Google Scholar]
  27. Kugiyama K., Kerns S. A., Morrisett J. D., Roberts R., Henry P. D. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature. 1990 Mar 8;344(6262):160–162. doi: 10.1038/344160a0. [DOI] [PubMed] [Google Scholar]
  28. Kugiyama K., Ohgushi M., Sugiyama S., Murohara T., Fukunaga K., Miyamoto E., Yasue H. Lysophosphatidylcholine inhibits surface receptor-mediated intracellular signals in endothelial cells by a pathway involving protein kinase C activation. Circ Res. 1992 Dec;71(6):1422–1428. doi: 10.1161/01.res.71.6.1422. [DOI] [PubMed] [Google Scholar]
  29. Kume N., Cybulsky M. I., Gimbrone M. A., Jr Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J Clin Invest. 1992 Sep;90(3):1138–1144. doi: 10.1172/JCI115932. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Kume N., Gimbrone M. A., Jr Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells. J Clin Invest. 1994 Feb;93(2):907–911. doi: 10.1172/JCI117047. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  32. Lindner V., Majack R. A., Reidy M. A. Basic fibroblast growth factor stimulates endothelial regrowth and proliferation in denuded arteries. J Clin Invest. 1990 Jun;85(6):2004–2008. doi: 10.1172/JCI114665. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Lundbaek J. A., Andersen O. S. Lysophospholipids modulate channel function by altering the mechanical properties of lipid bilayers. J Gen Physiol. 1994 Oct;104(4):645–673. doi: 10.1085/jgp.104.4.645. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Madri J. A., Reidy M. A., Kocher O., Bell L. Endothelial cell behavior after denudation injury is modulated by transforming growth factor-beta1 and fibronectin. Lab Invest. 1989 Jun;60(6):755–765. [PubMed] [Google Scholar]
  35. McMurray H. F., Parthasarathy S., Steinberg D. Oxidatively modified low density lipoprotein is a chemoattractant for human T lymphocytes. J Clin Invest. 1993 Aug;92(2):1004–1008. doi: 10.1172/JCI116605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Minick C. R., Stemerman M. G., Insull W., Jr Effect of regenerated endothelium on lipid accumulation in the arterial wall. Proc Natl Acad Sci U S A. 1977 Apr;74(4):1724–1728. doi: 10.1073/pnas.74.4.1724. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Montesano R., Orci L. Phorbol esters induce angiogenesis in vitro from large-vessel endothelial cells. J Cell Physiol. 1987 Feb;130(2):284–291. doi: 10.1002/jcp.1041300215. [DOI] [PubMed] [Google Scholar]
  38. Morel D. W., DiCorleto P. E., Chisolm G. M. Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation. Arteriosclerosis. 1984 Jul-Aug;4(4):357–364. doi: 10.1161/01.atv.4.4.357. [DOI] [PubMed] [Google Scholar]
  39. Murugesan G., Chisolm G. M., Fox P. L. Oxidized low density lipoprotein inhibits the migration of aortic endothelial cells in vitro. J Cell Biol. 1993 Feb;120(4):1011–1019. doi: 10.1083/jcb.120.4.1011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Murugesan G., Sa G., Fox P. L. High-density lipoprotein stimulates endothelial cell movement by a mechanism distinct from basic fibroblast growth factor. Circ Res. 1994 Jun;74(6):1149–1156. doi: 10.1161/01.res.74.6.1149. [DOI] [PubMed] [Google Scholar]
  41. Nakamura K., Handa S. Coomassie brilliant blue staining of lipids on thin-layer plates. Anal Biochem. 1984 Nov 1;142(2):406–410. doi: 10.1016/0003-2697(84)90484-6. [DOI] [PubMed] [Google Scholar]
  42. Natarajan V., Scribner W. M., Taher M. M. 4-Hydroxynonenal, a metabolite of lipid peroxidation, activates phospholipase D in vascular endothelial cells. Free Radic Biol Med. 1993 Oct;15(4):365–375. doi: 10.1016/0891-5849(93)90036-t. [DOI] [PubMed] [Google Scholar]
  43. Parthasarathy S., Barnett J. Phospholipase A2 activity of low density lipoprotein: evidence for an intrinsic phospholipase A2 activity of apoprotein B-100. Proc Natl Acad Sci U S A. 1990 Dec;87(24):9741–9745. doi: 10.1073/pnas.87.24.9741. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Parthasarathy S., Steinberg D., Witztum J. L. The role of oxidized low-density lipoproteins in the pathogenesis of atherosclerosis. Annu Rev Med. 1992;43:219–225. doi: 10.1146/annurev.me.43.020192.001251. [DOI] [PubMed] [Google Scholar]
  45. Pepper M. S., Ferrara N., Orci L., Montesano R. Leukemia inhibitory factor (LIF) inhibits angiogenesis in vitro. J Cell Sci. 1995 Jan;108(Pt 1):73–83. doi: 10.1242/jcs.108.1.73. [DOI] [PubMed] [Google Scholar]
  46. Portman O. W., Alexander M. Lysophosphatidylcholine concentrations and metabolism in aortic intima plus inner media: effect of nutritionally induced atherosclerosis. J Lipid Res. 1969 Mar;10(2):158–165. [PubMed] [Google Scholar]
  47. Portman O. W., Illingworth D. R. Lysolecithin binding to human and squirrel monkey plasma and tissue components. Biochim Biophys Acta. 1973 Oct 17;326(1):34–42. doi: 10.1016/0005-2760(73)90025-8. [DOI] [PubMed] [Google Scholar]
  48. Portman O. W., Illingworth D. R. Metabolism of lysolecithin in vivo and in vitro with particular emphasis on the arterial wall. Biochim Biophys Acta. 1974 Apr 26;348(1):136–144. doi: 10.1016/0005-2760(74)90099-x. [DOI] [PubMed] [Google Scholar]
  49. Quinn M. T., Parthasarathy S., Fong L. G., Steinberg D. Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Proc Natl Acad Sci U S A. 1987 May;84(9):2995–2998. doi: 10.1073/pnas.84.9.2995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Quinn M. T., Parthasarathy S., Steinberg D. Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis. Proc Natl Acad Sci U S A. 1988 Apr;85(8):2805–2809. doi: 10.1073/pnas.85.8.2805. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Reidy M. A., Clowes A. W., Schwartz S. M. Endothelial regeneration. V. Inhibition of endothelial regrowth in arteries of rat and rabbit. Lab Invest. 1983 Nov;49(5):569–575. [PubMed] [Google Scholar]
  52. Rosen E. M., Carley W., Goldberg I. D. Scatter factor regulates vascular endothelial cell motility. Cancer Invest. 1990;8(6):647–650. doi: 10.3109/07357909009018936. [DOI] [PubMed] [Google Scholar]
  53. Sa G., Fox P. L. Basic fibroblast growth factor-stimulated endothelial cell movement is mediated by a pertussis toxin-sensitive pathway regulating phospholipase A2 activity. J Biol Chem. 1994 Feb 4;269(5):3219–3225. [PubMed] [Google Scholar]
  54. Sakai M., Miyazaki A., Hakamata H., Sasaki T., Yui S., Yamazaki M., Shichiri M., Horiuchi S. Lysophosphatidylcholine plays an essential role in the mitogenic effect of oxidized low density lipoprotein on murine macrophages. J Biol Chem. 1994 Dec 16;269(50):31430–31435. [PubMed] [Google Scholar]
  55. Schmidt K., Klatt P., Graier W. F., Kostner G. M., Kukovetz W. R. High-density lipoprotein antagonizes the inhibitory effects of oxidized low-density lipoprotein and lysolecithin on soluble guanylyl cyclase. Biochem Biophys Res Commun. 1992 Jan 15;182(1):302–308. doi: 10.1016/s0006-291x(05)80145-7. [DOI] [PubMed] [Google Scholar]
  56. Schuh J., Fairclough G. F., Jr, Haschemeyer R. H. Oxygen-mediated heterogeneity of apo-low-density lipoprotein. Proc Natl Acad Sci U S A. 1978 Jul;75(7):3173–3177. doi: 10.1073/pnas.75.7.3173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Schwartz S. M., Gajdusek C. M., Selden S. C., 3rd Vascular wall growth control: the role of the endothelium. Arteriosclerosis. 1981 Mar-Apr;1(2):107–126. doi: 10.1161/01.atv.1.2.107. [DOI] [PubMed] [Google Scholar]
  58. Sparrow C. P., Parthasarathy S., Steinberg D. Enzymatic modification of low density lipoprotein by purified lipoxygenase plus phospholipase A2 mimics cell-mediated oxidative modification. J Lipid Res. 1988 Jun;29(6):745–753. [PubMed] [Google Scholar]
  59. Steinbrecher U. P., Parthasarathy S., Leake D. S., Witztum J. L., Steinberg D. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci U S A. 1984 Jun;81(12):3883–3887. doi: 10.1073/pnas.81.12.3883. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Subbaiah P. V., Chen C. H., Bagdade J. D., Albers J. J. Substrate specificity of plasma lysolecithin acyltransferase and the molecular species of lecithin formed by the reaction. J Biol Chem. 1985 May 10;260(9):5308–5314. [PubMed] [Google Scholar]
  61. Subbaiah P. V., Monshizadegan H. Substrate specificity of human plasma lecithin-cholesterol acyltransferase towards molecular species of phosphatidylcholine in native plasma. Biochim Biophys Acta. 1988 Dec 16;963(3):445–455. doi: 10.1016/0005-2760(88)90313-x. [DOI] [PubMed] [Google Scholar]
  62. Sugiyama S., Kugiyama K., Ohgushi M., Fujimoto K., Yasue H. Lysophosphatidylcholine in oxidized low-density lipoprotein increases endothelial susceptibility to polymorphonuclear leukocyte-induced endothelial dysfunction in porcine coronary arteries. Role of protein kinase C. Circ Res. 1994 Apr;74(4):565–575. doi: 10.1161/01.res.74.4.565. [DOI] [PubMed] [Google Scholar]
  63. Switzer S., Eder H. A. Transport of lysolecithin by albumin in human and rat plasma. J Lipid Res. 1965 Oct;6(4):506–511. [PubMed] [Google Scholar]
  64. Tauber J. P., Goldminz D., Gospodarowicz D. Up-regulation in vascular endothelial cells of binding sites of high density lipoprotein induced by 25-hydroxycholesterol. Eur J Biochem. 1981 Oct;119(2):327–339. doi: 10.1111/j.1432-1033.1981.tb05612.x. [DOI] [PubMed] [Google Scholar]
  65. Tokumura A., Mostafa M. H., Nelson D. R., Hanahan D. J. Stimulation of (Ca2+ + Mg2+)-ATPase activity in human erythrocyte membranes by synthetic lysophosphatidic acids and lysophosphatidylcholines. Effects of chain length and degree of unsaturation of the fatty acid groups. Biochim Biophys Acta. 1985 Jan 25;812(2):568–574. doi: 10.1016/0005-2736(85)90332-3. [DOI] [PubMed] [Google Scholar]
  66. Van Kessel W. S., Hax W. M., Demel R. A., De Gier J. High performance liquid chromatographic separation and direct ultraviolet detection of phospholipids. Biochim Biophys Acta. 1977 Mar 25;486(3):524–530. doi: 10.1016/0005-2760(77)90102-3. [DOI] [PubMed] [Google Scholar]
  67. Walker L. N., Bowyer D. E. Endothelial healing in the rabbit aorta and the effect of risk factors for atherosclerosis. Hypercholesterolemia. Arteriosclerosis. 1984 Sep-Oct;4(5):479–488. doi: 10.1161/01.atv.4.5.479. [DOI] [PubMed] [Google Scholar]
  68. Weltzien H. U. Cytolytic and membrane-perturbing properties of lysophosphatidylcholine. Biochim Biophys Acta. 1979 Aug 20;559(2-3):259–287. doi: 10.1016/0304-4157(79)90004-2. [DOI] [PubMed] [Google Scholar]
  69. Ylä-Herttuala S. Macrophages and oxidized low density lipoproteins in the pathogenesis of atherosclerosis. Ann Med. 1991;23(5):561–567. doi: 10.3109/07853899109150518. [DOI] [PubMed] [Google Scholar]
  70. Zetter B. R. Migration of capillary endothelial cells is stimulated by tumour-derived factors. Nature. 1980 May 1;285(5759):41–43. doi: 10.1038/285041a0. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES